New Owner
BioMarin Pharmaceutical - Prosensa
BioMarin Pharmaceutical acquires Prosensa
Announced: November 24, 2014
Type: Acquisition
Disposition: Separate Entity
Terms: Cash & Stock
Status: Complete
Amount: $ 840,000,000
